Beijing Sun-Novo Pharmaceutical Co., Ltd. logo

Beijing Sun-Novo Pharmaceutical Co., Ltd.

688621 · SSE · China

sun-novo.com

Financials as of FY2025

What stands out
  • Earnings significantly exceed cash generation
At a glance
  • Depends onMidstream position: 5 outgoing, 4 incoming connections
  • ScaleMarket cap is $1.25B, above the global median of $1.18B
  • FinancialsAltman Z-Score 6.49: safe zone
  • Interpretations3 currently firing — 3